Peripheral blood T cells and monocytes and B cell lines derived from patients with lupus express estrogen receptor transcripts similar to those of normal cells

Journal of Rheumatology

Volumn 25, Issue 7, 1998, Pages 1305-1312

  Suenaga, Ronsuke ^a,b,c   Evans, Marilyn J ^a,b   Mitamura, Ko ^a,b   Rider, Virginia ^a   Abdou, Nabih I ^a,b  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b St Luke's Hospital

^c ST LUKE S HOSPITAL   (United States)

Author keywords

Estrogen receptor; Immune cells; mRNA sequence; SLE

Indexed keywords

ESTROGEN RECEPTOR;

ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; HUMAN; HUMAN CELL; LUPUS ERYTHEMATOSUS; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RNA SEQUENCE; T LYMPHOCYTE;

ADULT; B-LYMPHOCYTES; CELL LINE, TRANSFORMED; ESTRADIOL; FEMALE; HUMANS; IONOMYCIN; LUPUS ERYTHEMATOSUS, SYSTEMIC; MONOCYTES; POLYMERASE CHAIN REACTION; RECEPTORS, ESTROGEN; RNA, MESSENGER; SEQUENCE ANALYSIS; T-LYMPHOCYTES; TETRADECANOYLPHORBOL ACETATE;

EID: 0031838044     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Distelhorst CW. Steroid hormone receptors. J Lab Clin Med 1993;122:241-4.
2. Gulshan S, McCruden, Stimson WH. Oestrogen receptors in macrophages. Scand J Immunol 1990;31:691-7.
3. Wada K, Itoh T, Nakagawa M, Misao R, Mori H, Tamaya T. Estrogen binding sites in peripheral blood monocytes and effects of danazol on their sites in vitro. Gen Pharmacol 1992;23:693-700.
4. Cutolo M, Accardo S, Villaggio B, et al. Presence of estrogen-binding sites on macrophage-like synoviocytes and CD8+, CD29+, CD45RO+ T lymphocytes in normal and rheumatoid synovium. Arthritis Rheum 1993;36:1087-97.
5. Uchiyama T, Inoue K, Nishioka J. Expression of estrogen receptor related protein (p29) and estradiol binding in human arthritic synovium. J Rheumatol 1995;22:421-6.
6. Ben-Hur H, Mor G, Insler V, et al. Menopause is associated with a significant increase in blood monocyte number and a relative decrease in the expression of estrogen receptors in human peripheral monocytes. Am J Reprod Immunol 1995;34:363-9.
7. Cutolo M, Accardo S, Villaggio B, et al. Androgen and estrogen receptors are present in primary cultures of human synovial macrophages. J Clin Endocrinol Metab 1996;81:820-7.
8. Suenaga R, Mitamura K, Evans MJ, Abdou NI. Binding affinity and quantity of estrogen receptor in peripheral blood monocytes of patients with systemic lupus erythematosus. Lupus 1996;5:227-31.
9. Cohen JHM, Danel L, Cordier G, Saez S, Revillard J-P. Sex steroid receptors in peripheral T cells: absence of androgen receptors and restriction of estrogen receptors to OKT8-positive cells. J Immunol 1983;131:2767-71.
10. Weusten JJAM, Blankenstein MA, Gmelig-Meyling FHJ, Schuurman HJ, Karter L, Thijssen JHH. Presence of oestrogen receptors in human blood mononuclear cells and thymocyte. Acta Endocrinol 1986;112:409-14.
11. Stimson WH. Oestrogen and human T lymphocytes: presence of specific receptors in the T-suppressor/cytotoxic subset. Scand J Immunol 1988;28:345-50.
12. Ahmed SA, Talal N. Importance of sex hormones in systemic lupus erythematosus. In: Wallace DJ, Hahn BH, editors. Dubois' Lupus Erythematosus. Philadelphia: Lea & Febiger, 1993:148-56.
13. Lahita RG. The importance of estrogen in systemic lupus erythematosus. Clin Immunol Immunopathol 1992;63:17-8.
14. Steinberg AD, Melez KA, Raveche ES, et al. Approach to the study of the role of sex hormones in autoimmunity. Arthritis Rheum 1979;22:1170-6.
15. Roubinian JR, Talal N, Greenspan JS, Siiteri PK. Effects of castration and sex hormone treatment on survival, anti-nucleic acid antibodies and glomerulonephritis in NZB/NZW F1 mice. J Exp Med 1983;147:1568-83.
16. Carlsten H, Nilsson N, Jonsson R, Backman K, Holmdahl R, Tarkowski A. Estrogen accelerates immune complex glomerulonephritis but ameliorates T cell-mediated vasculitis and sialadenitis in autoimmune MRL lpr/lpr mice. Cell Immunol 1992;144:190-202.
17. Travers RL, Hughes RV. Oral contraceptive therapy and systemic lupus erythematosus. J Rheumatol 1978;5:448-51.
18. Garovich M, Agudelo C, Pisko E. Oral contraceptives and systemic lupus erythematosus. Arthritis Rheum 1980;23:1396-8.
19. Lahita RG, Bradlow HL, Kunkel HG, Fishman J. Increased 16 alpha hydroxylation of estradiol in systemic lupus erythematosus. J Clin Endocrinol Metab 1981;53:174-8.
20. Junger P, Dougados M, Pelissier C, et al. Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus. Arthritis Rheum 1982;25:618-23.
21. Ben-Chetrit A, Ben-Chetrit E. Systemic lupus erythematosus by ovulation induction treatment. Arthritis Rheum 1994;37:1614-7.
22. Sanchez-Guerrero J, Liang MH, Karlson EW, Hunter DJ, Colditz GA. Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus. Ann Intern Med 1995;122:430-3.
23. Sanchez-Guerrero J, Karlson EW, Liang MH, Hunder DJ, Speizer FE, Coldtiz GA. Past use of oral contraceptives and the risk of developing systemic lupus erythematosus. Arthritis Rheum 1997;40:804-8.
24. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
25. Bombardier C, Gladman FD, Urowitz MB, Caron D, Chang CH, the Committee on Prognosis Studies in SLE. Derivation of the SLEDAI. A disease activity index for lupus patients. Arthritis Rheum 1992;35:630-40.
26. Mitamura K, Suenaga R, Wilson KB, Abdou NI. V gene sequences of human anti-ssDNA antibodies secreted by lupus-derived CD5-negative B cell hybridomas. Clin Immunol Immunopathol 1996;78:152-60.
27. Suenaga R, Mitamura K, Abdou NI. V gene sequences of lupus-derived human IgM anti-ssDNA antibody: implication for the importance of the location of DNA-binding amino acids. Clin Immunol Immunopathol 1998;86:72-80.
28. Green S, Walter P, Krust V, Bornet JM, Argos P, Chambon P. Human estrogen receptor cDNA: sequence, expression and homology to v-erb A. Nature 1986;320:134-9.
29. Fuqua SAW, Fitzgerald SD, Chamness GC, et al. Variant human breast tumor estrogen receptor with constitutive transcriptional activity. Cancer Res 1991;51:105-9.
30. Wang Y, Milksicek RJ. Identification of a dominant negative form of the human estrogen receptor. Mol Endocrinol 1991;5:1707-15.
31. Gilmore W, Weiner LP, Correale J. Effect of estradiol on cytokine secretion by proteolipid protein-specific T cell clones isolated from multiple sclerosis patients and normal control subjects. J Immunol 1997;158:446-51.
32. Ahmed SA, Dauphinee MJ, Montoya AI, Talal N. Estrogen induces normal murine CD5+ B cells to produce autoantibodies. J Immunol 1989;142:2647-53.
33. Fuqua SAW, Fitzgerald SD, Allred DC, et al. Inhibition of estrogen receptor action by a naturally occurring variant in human breast tumors. Cancer Res 1992;52:483-6.
34. Koehorst SG, Jacobs HM, Thijssen JHH, Blankenstein MA. Wild type and alternatively spliced estrogen receptor messenger RNA in human meningioma tissue and MCF7 breast cancer cells. J Steroid Biochem Mol Biol 1993;45:227-33.
35. Rea D, Parker MG. Effects of an exon 5 variant of the estrogen receptor in MCF-7 breast cancer cells. Cancer Res 1996;56:1556-63.
36. Pfeffer U, Fecarotta E, Arena G, Forlani A, Vidali G. Alternative splicing of the estrogen receptor primary transcript normally occurs in estrogen receptor positive tissues and cell lines. J Steroid Biochem Mol Biol 1996;56:99-105.
37. Leygue ER, Watson PH, Murphy LC. Estrogen receptor variants in normal human mammary tissue. J Natl Cancer Inst 1996;88:284-90.
38. Pink JJ, Jordan VC. Models of estrogen receptor regulation by estrogens and antiestrogens in breast cancer cell lines. Cancer Res 1996;56:2321-30.
39. Shah NN, Faaland CA, Thomas T, Sigal LH, Thomas TJ. Estradiol analogs and polyamines alter the binding affinity of estrogen receptor with estrogen response element: potential implication for estrogenic action in lupus [abstract]. Arthritis Rheum 1996;39 suppl:S109.
40. Hyder SM, Stancel GM, Nawaz A, McDonnell DP, Loose-Mitchell DS. Identification of an estrogen response element in the 3′-flanking region of the murine c-fos protooncogene. J Biol Chem 1992;267:18047-9054.
41. Rider V, Carlone DL, Foster RT. Oestrogen and progesterone control of basic fibroblast growth factor mRNA in the rat uterus. J Endocrinol 1997;154:75-84.
42. Evans MJ, MacLaughlin S, Marvin RD, Abdou NI. Estrogen decreases in vivo apoptosis of peripheral blood mononuclear cells from women with normal menstrual cycles and decreases TNF-α production in SLE but not in normal cultures. Clin Immunol Immunopathol 1997;82:258-62.
43. Stein B, Yang MX. Repression of interleukin-6 promotor by estrogen receptor is mediated by NF-kB and C/EBPß. Mol Cell Biol 1995;15:4971-9.
44. Musci MA, Latinis KM, Koretzy GA. Signaling events in T lymphocytes leading to cellular activation or programmed cell death. Clin Immunol Immunopathol 1997;83:205-22.
45. Rider V, Evans MJ, Suenaga R, Abdou NI. Gender differences in autoimmunity; Estrogen increases calcineurin in systemic lupus erythematosus [abstract]. Lupus 1998;7 Suppl:117.